Medicon Hellas S.A. (ATH:MEDIC)
Greece
· Delayed Price · Currency is EUR 2.370
+0.070 (3.04%)
At close: Jun 20, 2025, 5:20 PM EET
Medicon Hellas Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 18.12 | 18.12 | 20.77 | 21.51 | 15.27 | Upgrade
| |
Revenue Growth (YoY) | 0.03% | -12.77% | -3.41% | 40.87% | 13.51% | Upgrade
|
Cost of Revenue | 5.24 | 5.1 | 5.29 | 5.82 | 3.99 | Upgrade
|
Gross Profit | 12.88 | 13.02 | 15.48 | 15.69 | 11.28 | Upgrade
|
Selling, General & Admin | 10.29 | 10.45 | 10.99 | 10.13 | 8.82 | Upgrade
|
Research & Development | 0.93 | 0.92 | 0.77 | 0.91 | 0.84 | Upgrade
|
Other Operating Expenses | 0.01 | -0.14 | -0.12 | -0.34 | 0.05 | Upgrade
|
Operating Expenses | 11.23 | 11.24 | 11.63 | 10.7 | 9.7 | Upgrade
|
Operating Income | 1.65 | 1.78 | 3.85 | 4.99 | 1.58 | Upgrade
|
Interest Expense | -0.58 | -0.58 | -0.26 | -0.27 | -0.3 | Upgrade
|
Interest & Investment Income | 0.41 | 0.58 | 0.15 | 0.13 | 0.23 | Upgrade
|
Currency Exchange Gain (Loss) | 0 | -0 | -0.01 | -0.02 | 0.01 | Upgrade
|
Other Non Operating Income (Expenses) | -0.17 | -0.31 | -0.07 | -0.08 | -0.07 | Upgrade
|
EBT Excluding Unusual Items | 1.31 | 1.47 | 3.66 | 4.74 | 1.45 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.12 | -0 | 0 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.01 | 0.02 | -0 | 0.03 | -0 | Upgrade
|
Pretax Income | 1.42 | 1.5 | 3.66 | 4.78 | 1.45 | Upgrade
|
Income Tax Expense | 0.19 | 0.27 | 0.96 | 1.54 | 0.63 | Upgrade
|
Earnings From Continuing Operations | 1.23 | 1.23 | 2.7 | 3.24 | 0.82 | Upgrade
|
Earnings From Discontinued Operations | 0.05 | 0.11 | - | - | - | Upgrade
|
Net Income to Company | 1.28 | 1.34 | 2.7 | 3.24 | 0.82 | Upgrade
|
Minority Interest in Earnings | 0.08 | -0.01 | -0.17 | -0.2 | -0.06 | Upgrade
|
Net Income | 1.37 | 1.32 | 2.53 | 3.04 | 0.76 | Upgrade
|
Net Income to Common | 1.37 | 1.32 | 2.53 | 3.04 | 0.76 | Upgrade
|
Net Income Growth | 3.38% | -47.83% | -16.68% | 301.85% | -2.40% | Upgrade
|
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
EPS (Basic) | 0.31 | 0.30 | 0.57 | 0.69 | 0.17 | Upgrade
|
EPS (Diluted) | 0.31 | 0.30 | 0.57 | 0.69 | 0.17 | Upgrade
|
EPS Growth | 3.38% | -47.83% | -16.68% | 301.85% | -2.40% | Upgrade
|
Free Cash Flow | 1 | -0.72 | 0.84 | 4.24 | 2.34 | Upgrade
|
Free Cash Flow Per Share | 0.23 | -0.16 | 0.19 | 0.96 | 0.53 | Upgrade
|
Dividend Per Share | - | 0.060 | 0.153 | - | - | Upgrade
|
Dividend Growth | - | -60.82% | - | - | - | Upgrade
|
Gross Margin | 71.07% | 71.86% | 74.52% | 72.94% | 73.90% | Upgrade
|
Operating Margin | 9.10% | 9.84% | 18.52% | 23.18% | 10.35% | Upgrade
|
Profit Margin | 7.54% | 7.29% | 12.20% | 14.14% | 4.96% | Upgrade
|
Free Cash Flow Margin | 5.49% | -3.95% | 4.05% | 19.70% | 15.33% | Upgrade
|
EBITDA | 2.93 | 3.08 | 5.09 | 6.13 | 2.48 | Upgrade
|
EBITDA Margin | 16.16% | 17.02% | 24.52% | 28.51% | 16.21% | Upgrade
|
D&A For EBITDA | 1.28 | 1.3 | 1.25 | 1.14 | 0.9 | Upgrade
|
EBIT | 1.65 | 1.78 | 3.85 | 4.99 | 1.58 | Upgrade
|
EBIT Margin | 9.10% | 9.84% | 18.52% | 23.18% | 10.35% | Upgrade
|
Effective Tax Rate | 13.08% | 18.23% | 26.14% | 32.15% | 43.70% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.